Tuesday, June 26, 2012- Hershey’s Long-Term Sales Look SWEET and 3 Analyst Alerts in Our Sightsat Wall St. Cheat Sheet (Tue, 26 Jun)
- Issuance Of Complete Response Letter For Eliquis Doesn't Alter My Buy On Bristol-Myers Squibbat Seeking Alpha (Tue, 26 Jun)
- S&P 500 Insider Stock Sales You Must Knowat Wall St. Cheat Sheet (Tue, 26 Jun)
- Bristol-Myers' Eliquis U.S. forecasts pushed out 12 months at Leerinkat theflyonthewall.com (Tue, 26 Jun)
- Healthcare Biz Recap: FDA PROBES Pfizer’s New Drug, Ventrus Biosciences ABANDONS Treatmentat Wall St. Cheat Sheet (Tue, 26 Jun)
- FDA delays decision on Pfizer, Bristol-Myers drugAP (Tue, 26 Jun)
- Stocks Edge Off Session Lows; Teva, Anheuser Busch Climbat Investor's Business Daily (Tue, 26 Jun)
- 1 Reason for the Dow's Monday Tank Jobat Motley Fool (Tue, 26 Jun)
- As Pharma Ticks Higher, Managing Directors Share Picksat CNBC (Tue, 26 Jun)
- News Summary: FDA again delays anticlotting drugAP (Tue, 26 Jun)
- Stocks Near Lows In Afternoon; Drugmaker Shire Dropsat Investor's Business Daily (Tue, 26 Jun)
- Top 10 Holdings From Texas Money Management Firmat Seeking Alpha (Tue, 26 Jun)
- Why Merck Could Go Even Higherat Motley Fool (Tue, 26 Jun)
- FDA Once Again Delays Approval Of Apixaban (Eliquis)at Forbes (Tue, 26 Jun)
- Nasdaq Falls 2% As Market Tumbles Broadlyat Investor's Business Daily (Tue, 26 Jun)
Monday, June 25, 2012- Johnson & Johnson Shares Positioned To Leap Higherat Seeking Alpha (Mon, 25 Jun)
- Pfizer, Bristol-Myers Dealt Approval Setback on Blood Thinner Eliquisat Minyanville (Mon, 25 Jun)
- Stroke Drug From Pfizer, Bristol-Myers Hits Snagat Investor's Business Daily (Mon, 25 Jun)
- Stocks Open In The Red: Teva Pharmaceuticals Surgesat Investor's Business Daily (Mon, 25 Jun)
- Ventrus Biosciences IMPLODES 58% and 4 Stocks with Horrible News Nowat Wall St. Cheat Sheet (Mon, 25 Jun)
- Valuing Biotech: It's The Future, Stupidat Seeking Alpha (Mon, 25 Jun)
- Stocks Futures Aim Low; Bristol Myers Squibb Tumblesat Investor's Business Daily (Mon, 25 Jun)
- Pfizer, Bristol-Myers’ Eliquis Drug Fails to Win FDA Approvalat Bloomberg (Mon, 25 Jun)
- FDA: Amylin Pharma Concealed Heart Safety Risks of Key Diabetes Drugat TheStreet (Mon, 25 Jun)
- 3 Sectors That'll Break Out the Champagne If Obamacare Is Upheldat Motley Fool (Mon, 25 Jun)
| |
|
1.77%